Norepinephrine Versus Ephedrin for Prevention of Post Spinal Anesthesia in Cesarean Section

Cesarean Clinical Trial

Official title: Norepinephrine Versus Ephedrin for Prevention of Post Spinal Anesthesia in Cesarean Section

Status Not yet recruiting

Clinical Trial Summary

Spinal anesthesia is still the gold standard anesthetic method for elective and urgent cesarean section, the post spinal hypotension remains the most frequent complication of this procedure and is still responsible of considerable maternel and fetal morbidity. It is recommanded to prevent this post spinal hypotension with fluid coloading and prophylactic vasopressors administration.

The aim of this study is to compare the efficency and the safety of norepinephrin and ephedrin prophylactic administration to reduce the incidence of post spinal hypotension in cesarean section.

Clinical Trial Description

Spinal anesthesia is still the gold standard anesthetic method for elective and urgent cesarean section, the post spinal hypotension remains the most frequent complication of this procedure and is still responsible of considerable maternel and fetal morbidity. It is recommanded to prevent this post spinal hypotension with fluid coloading and prophylactic vasopressors administration. The prophylactic use of norepinephrin and phenylephrin has been validated by several studies, but few data are published concerning the comparaison between norepinephrin and ephedrine as preventive vasopressors in cesarean section; these molecules act on alpha and beta adrenergic receptors and could provide better maternal hemodynamics in parturients undergoing cesarean section under spinal anesthesia.

The aim of this study is to compare the efficency and the safety of norepinephrin and ephedrin prophylactic administration to reduce the incidence of post spinal hypotension in cesarean section. ;

Related Conditions & MeSH terms

• Cesarean
• Hypotension
• Maternal Hypotension Syndrome
• Obstetric Labor Complications

• NCT number: NCT03719625
• Study type: Interventional
• Source: Mongi Slim Hospital
• Contact: Asma Ben Souissi, assistant professor
• Phone: 0021698336883
• Email: bsouissiasma@gmail.com
• Status: Not yet recruiting
• Phase: Phase 4
• Start date: January 2, 2019
• Completion date: May 30, 2019